login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEURAXIS INC (NRXS) Stock News
USA
- NYSEARCA:NRXS -
US64134X2018
-
Common Stock
3.03
USD
-0.04 (-1.3%)
Last: 10/14/2025, 8:04:02 PM
2.97
USD
-0.06 (-1.98%)
Pre-Market:
10/15/2025, 7:16:10 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NRXS Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Benzinga
- Mentions:
IVA
BOLT
ENGN
RLMD
...
12 Health Care Stocks Moving In Thursday's After-Market Session
2 months ago - By: Zacks Investment Research
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
2 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
2 months ago - By: Benzinga
Earnings Outlook For Neuraxis
2 months ago - By: NeurAxis, Inc.
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
5 months ago - By: NeurAxis, Inc.
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
a year ago - By: InvestorPlace
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024
a year ago - By: NeurAxis, Inc.
NeurAxis Reports Second Quarter 2024 Financial Results
4 months ago - By: NeurAxis, Inc.
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
4 months ago - By: NeurAxis, Inc.
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
5 months ago - By: NeurAxis, Inc.
NeurAxis Announces $5.0 Million Registered Direct Offering
5 months ago - By: Yahoo Finance
- Mentions:
MS
COMP
UNH
CWGL
...
Equities Rise Intraday as Markets Weigh Macro Data, Fed Chair's Comments
5 months ago - By: Zacks Investment Research
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
5 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
5 months ago - By: NeurAxis, Inc.
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
6 months ago - By: Zacks Investment Research
- Mentions:
JNJ
CSCO
AMZN
EFX
...
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems
6 months ago - By: NeurAxis, Inc.
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
7 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
7 months ago - By: NeurAxis, Inc.
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
9 months ago - By: NeurAxis, Inc.
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
9 months ago - By: NeurAxis, Inc.
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
9 months ago - By: NeurAxis, Inc.
NeurAxis Inc. Issues Letter to Shareholders
9 months ago - By: NeurAxis, Inc.
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
9 months ago - By: NeurAxis, Inc.
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
10 months ago - By: NeurAxis, Inc.
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
a year ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
a year ago - By: NeurAxis, Inc.
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
a year ago - By: NeurAxis, Inc.
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024
a year ago - By: NeurAxis, Inc.
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation
a year ago - By: NeurAxis, Inc.
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
a year ago - By: NeurAxis, Inc.
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
a year ago - By: NeurAxis, Inc.
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
Please enable JavaScript to continue using this application.